Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical hold
Biotech
FDA puts Intellia CRISPR trials on hold over raised liver enzyme
After Intellia paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the FDA has made things official.
James Waldron
Oct 30, 2025 6:37am
Rocket's gene therapy free from FDA hold
Aug 20, 2025 10:40am
Another biotech hit with FDA delay for ALS asset
Aug 18, 2025 11:01am
FDA slaps clinical hold across all of Sarepta’s LGMD trials
Jul 21, 2025 11:36am
Fierce Pharma
Sarepta will continue shipping Elevidys despite FDA misgivings
Jul 21, 2025 10:42am
Kezar sees hepatitis hold lifted, mulls restarting lupus program
Jul 16, 2025 8:47am